Cyclacel Pharmaceuticals (CYCC)

Add to Watchlists
Create an Alert
3.28 +0.11  +3.47% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
CYCC Price Chart
View All Events

CYCC Events

Date Type Description
Mar 25 Misc Cyclacel Pharmaceuticals, Inc. Q4 2013 Earnings Conference Call
Mar 25 Earnings Cyclacel Pharmaceuticals, Inc. Q4 2013 Earnings Results. Estimate: -0.36.
Nov 12 Misc Cyclacel Pharmaceuticals to Release Third Quarter 2013 Financial Results Conference Call Date
Nov 12 Earnings Cyclacel Pharmaceuticals to Release Third Quarter 2013 Financial Results. Estimate: -0.33.
Aug 14 Misc Second Quarter 2013 Financial Results
Aug 14 Earnings Cyclacel Reports Second Quarter 2013 Financial Results.
May 13 Misc Cyclacel Pharmaceuticals to Announce Release of First Quarter 2013 Financial Earnings Call
May 13 Earnings Cyclacel Pharmaceuticals to Announce Release of First Quarter 2013 Financial Results.
View All Performance Charts

CYCC Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cyclacel Pharmaceuticals is down 34.40% over the last year vs S&P 500 Total Return up 22.72%, Exelixis down 32.02%, and Dyax up 64.55%.

Get Quote for
Advertisement

Portfolio Strategies Featuring CYCC

Did Cyclacel Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CYCC Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Cyclacel Pharmaceuticals, Inc., is a development-stage biopharmaceutical company engaged in the development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious diseases.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CYCC 3.28 +0.11 +3.47% 65.01M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.